Page last updated: 2024-09-02

higenamine and Dihydrotanshinone I

higenamine has been researched along with Dihydrotanshinone I in 1 studies

Compound Research Comparison

Studies
(higenamine)
Trials
(higenamine)
Recent Studies (post-2010)
(higenamine)
Studies
(Dihydrotanshinone I)
Trials
(Dihydrotanshinone I)
Recent Studies (post-2010) (Dihydrotanshinone I)
13647088074

Protein Interaction Comparison

ProteinTaxonomyhigenamine (IC50)Dihydrotanshinone I (IC50)
Replicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus3.05
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.59
AcetylcholinesteraseHomo sapiens (human)1
Tyrosine-protein phosphatase non-receptor type 6Homo sapiens (human)3.67
Tyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)3.94
ELAV-like protein 1Homo sapiens (human)0.1085
Hypoxia-inducible factor 1-alphaHomo sapiens (human)2.17
Endothelial PAS domain-containing protein 1Homo sapiens (human)2.17

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bai, R; He, X; Wang, S; Xie, T; Ye, XY; Ye, Y; Zhang, H; Zhang, Y1

Reviews

1 review(s) available for higenamine and Dihydrotanshinone I

ArticleYear
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
    European journal of medicinal chemistry, 2022, Mar-05, Volume: 231

    Topics: Drug Discovery; Histone Demethylases; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Structure-Activity Relationship

2022